Edgewise Therapeutics, Inc. (NASDAQ: EWTX)
$27.0400
-0.6800 ( -0.44% ) 232.4K
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.
Market Data
Open
$27.0400
Previous close
$27.7200
Volume
232.4K
Market cap
$2.53B
Day range
$26.2900 - $27.9000
52 week range
$9.0000 - $38.1200
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 15 | May 07, 2024 |
| 4 | Insider transactions | 1 | May 07, 2024 |
| 3 | Insider transactions | 2 | May 07, 2024 |
| 4 | Insider transactions | 2 | May 03, 2024 |
| 4 | Insider transactions | 1 | May 03, 2024 |
| 4 | Insider transactions | 1 | May 03, 2024 |
| 4 | Insider transactions | 1 | May 03, 2024 |
| 4 | Insider transactions | 1 | May 03, 2024 |
| 4 | Insider transactions | 1 | May 03, 2024 |
| def | Proxies and info statements | 22 | Apr 26, 2024 |